O'Kane Kieran 4
4 · BIODESIX INC · Filed Jan 6, 2026
Insider Transaction Report
Form 4
BIODESIX INCBDSX
O'Kane Kieran
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to Buy)
2026-01-02+27,000→ 27,000 totalExercise: $6.46Exp: 2036-01-01→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]This option vests in a series of forty-eight successive, substantially equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date.